QA: ALX Oncology Holdings INC in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001810182_2021_ALX_Oncology_Holdings_INC.pdf

Logs

Graph

Absolute values for 0001810182, ALX Oncology Holdings INC

  xvar xval
0 AssetsCurrent 435,992,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 52,000
3 remainder_Assets 10,000
4 LiabilitiesCurrent 6,204,000
5 LiabilitiesNoncurrent 5,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,809,000
9 ResearchAndDevelopmentExpense 28,961,000
10 remainder_Expenses 1,720,000
11 remainder_Revenues 1,182,000
12 remainder_NetIncome -1,432,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 436,054,000
1 Liabilities 6,209,000
2 Expenses 45,490,000
3 Revenues 1,182,000
4 StockholdersEquity 429,845,000
5 NetIncome -45,740,000
6 ComprehensiveNetIncome -45,740,000
7 BaseVar 245,183,500
8 EconomicCapitalRatiobeforeLimitedLiability 4.03
9 EconomicCapitalRatio 4.42

Edgar->Model Mapping

Feature Distribution